Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on May 20, 2025
Longeveron® to Attend BIO International Convention 2025
GlobeNewswire
·
May 20, 2025
Focus on potential partnership and strategic opportunities for the Company’s stem cell therapy program for Alzheimer’s disease Recent Type B meeting with FDA provided alignment on a planned single, pivotal Phase 2/3 clinical trial, which if positive, would …
Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
GlobeNewswire
·
May 20, 2025
– Rademikibart significantly improved airway function, as measured by FEV1, within a day and significantly reduced acute exacerbations in patients with inflammation-mediated chronic asthma strongly supporting ongoing Phase 2 acute exacerbation studies in …
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI
GlobeNewswire
·
May 20, 2025
CINCINNATI, Ohio and ST. PAUL, Minn., May 20, 2025 (GLOBE NEWSWIRE) -- Ensemble, an industry leading revenue cycle management company, announced a strategic partnership today with Solventum, a market leader and innovator in AI-driven revenue cycle …
Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
GlobeNewswire
·
May 20, 2025
Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve …
ZyVersa Therapeutics Highlights Published Study Reinforcing That Microglia-driven Inflammation Is Pivotal in Development of Parkinson’s and Alzheimer’s Diseases
GlobeNewswire
·
May 20, 2025
Study results corroborate our recently published data demonstrating the critical role of microglial-driven inflammation in promoting accumulation and spread of toxic phosphorylated alpha-synuclein leading to neurodegeneration in Parkinson’s Disease (PD). …
Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals
GlobeNewswire
·
May 20, 2025
Females with ADHD frequently present with inattentive symptoms, which can be more difficult to recognize than the hyperactive and impulsive symptoms more often seen in males Boys are two times more likely to be diagnosed with ADHD than girls, leaving many …
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake
GlobeNewswire
·
May 20, 2025
SEATTLE and VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
GlobeNewswire
·
May 20, 2025
Latest developments expand Predictive’s AI-driven drug discovery platform to include biomarker discovery and drug repurposing With the global biomarker discovery market valued at $14.5 billion in 2024 and projected to grow at a 19.4% CAGR through 2030, …
Natural Remedies Introduces Ashwa.30, a Next-Gen Ashwagandha for Energy, Endurance and Stress Support
GlobeNewswire
·
May 20, 2025
BANGALORE, India, May 20, 2025 (GLOBE NEWSWIRE) -- Natural Remedies, a global leader in botanical branded ingredients, announces the launch of Ashwa.30, a next-generation ashwagandha extract designed to improve energy, boost endurance, and support stress …
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
GlobeNewswire
·
May 20, 2025
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that Mai-Britt Zocca, PhD, the company’s …
Mersana Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 20, 2025
CAMBRIDGE, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …
Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma
GlobeNewswire
·
May 20, 2025
Preconditioning with lymphodepletion linked to stronger MAR-T cells response and suggests enhanced anti-tumor activity Highest enrollment since study launch underscores momentum and signals a positive trial trajectory Clinical data readout from Phase 1 …
中国患者越来越多的JY整形外科皮肤科扩大韩中美容医疗交流
EIN Presswire
·
May 20, 2025
对Ulthera·钛提拉术、皮肤助推器等高功能施术的需求增加 继中国医疗团队访问之后, 正式开始交流, 确认K-美容的地位 SEOUL, GANGNAM, SOUTH KOREA, May 20, 2025 /EINPresswire.com/ -- 位于首尔清潭洞的JY整形外科皮肤科继中国医疗团队的正式访问之后, 当地患者也接连访问, 作为韩中美容医疗交流的中心备受关注。 据JY整形外科皮肤科透露, 最近中国患者的访问次数不断增加, 特别是对Ulthera …
Resonance of the Soul - Flowers & Harmonics—A Poetic Journey by Dr. Ivan Edwards
EIN Presswire
·
May 20, 2025
Dr. Ivan Edwards unveils a powerful anthology of poetry that speaks to the soul, coming soon to Amazon. SAN ANTONIO, TX, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- Dr. Ivan Edwards Announces Upcoming Poetry Anthology—"Resonance of the Soul: …
Reflect Scientific Receives Over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients
GlobeNewswire
·
May 20, 2025
OREM, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic and refrigeration technologies, announced today it has received over $250,000 in new orders for its high-performance freezer systems. The …
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
GlobeNewswire
·
May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Reviva to Participate in Upcoming Investor Conferences in May 2025
GlobeNewswire
·
May 20, 2025
CUPERTINO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Medela Introduces Magic InBra™ With FluidFeel Technology™—Where Science Meets Uncompromising Care
GlobeNewswire
·
May 20, 2025
Baar, Switzerland, May 20, 2025 (GLOBE NEWSWIRE) -- Research-Driven Innovation Highlights: FluidFeel Technology™: Developed through extensive lactation research, this feature creates an optimized pumping environment by allowing warm milk circulation …
Enlivex Selected to Present at Israeli BioMed 2025 Conference
GlobeNewswire
·
May 20, 2025
Presentation to highlight Allocetra™ and the therapeutic potential of macrophage reprogramming in inflammatory diseases Ness-Ziona, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage …
Devereux Georgia expands foster care services to Savannah
GlobeNewswire
·
May 20, 2025
KENNESAW, Ga., May 20, 2025 (GLOBE NEWSWIRE) -- Devereux Advanced Behavioral Health Georgia today announced it is now serving the Savannah, Georgia, foster care community, expanding its reach to provide critical care, support and stability for youth and …